From Monday, March 7th through Friday, March 11th, Widener Law’s Health Law Institute will hold the 2011 Regulatory Compliance & Analysis Program for Pharmaceutical & Corporate Industries on the Delaware campus.
Pharmaceutical and Corporate industry compliance officers, risk managers, legal counsel, quality assurance managers, professionals and students seeking careers in related professions are encouraged to attend the program, which offers either a Pharmaceutical Compliance track or a Corporate Compliance track.
Each track provides 28 credit hours towards certification by the Compliance Certification Board (CCB) under the auspices of the Health Care Compliance Association or the Society of Corporate Compliance and Ethics. Widener Law is only two law schools accredited by the Compliance Certification Board for the Health Care Compliance Association (HCCA) and the Society for Corporate Compliance and Ethics (SCCE).
Interested parties are encouraged to visit the 2011 Regulatory Compliance & Analysis Program for Pharmaceutical & Corporate Industries page
, which includes a full schedule and a list of speakers
This program is made possible through an educational grant from AstraZeneca U.S.